Next-generation glioblastoma multiforme therapies based on multistage delivery nanovectors [ 2016 - 2020 ]

Research Grant

[Cite as]

Brief description Nanomedicine provides novel therapies with enhanced treatment success and reduced side effects, which improve the patient’s quality of life. Drug delivery systems that are able to treat highly drug-resistant tumours such as glioblastoma multiforme (GBM) are a key target for nanomedicine-based therapies. We will investigate a new GBM treatment by developing a multistage delivery nanovector to selectively carry and release a combination of chemical and physical therapeutics.

Funding Amount $AUD 341,749.41

Funding Scheme Early Career Fellowships

Notes Peter Doherty Biomedical ECF

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]